AstraZeneca – Page 16 – THE OVAL CIRCLE

‘Average’ effectiveness & unexplained side effects: 7 QUESTIONS that AstraZeneca needs to answer about its Covid-19 vaccine

Posted on November 25, 2020November 25, 2020By Editor

The drug manufacturer AstraZeneca said on Monday it would seek emergency authorization for its coronavirus vaccine with various regulators. However, it might first have to answer a number of serious questions about its jab. … Read More >‘Average’ effectiveness & unexplained side effects: 7 QUESTIONS that AstraZeneca needs to answer about its Covid-19 vaccine

AstraZeneca’s Covid-19 vaccine shows average efficacy of 70%

Posted on November 24, 2020November 24, 2020By Editor

The coronavirus vaccine developed by the University of Oxford and drug maker AstraZeneca has shown an average efficacy of 70 percent, depending on dosage, the partners said as they announced clinical trial results. … Read More >AstraZeneca’s Covid-19 vaccine shows average efficacy of 70%

Highly anticipated AstraZeneca Covid vaccine to miss 30 million delivery target by 9 months – UK vaccine tsar

Posted on November 6, 2020November 6, 2020By Editor

British pharmaceutical giant AstraZeneca has failed to hit its target of delivering 30 million Covid-19 vaccines to the UK by the end of September and will only supply four percent of the promised 100 million doses this year. … Read More >Highly anticipated AstraZeneca Covid vaccine to miss 30 million delivery target by 9 months – UK vaccine tsar

‘We’re not there yet’: British health minister dashes hopes AstraZeneca vaccine could be ready before Christmas

Posted on October 27, 2020October 27, 2020By Editor

The British minister of health has rebuffed claims that a UK vaccine could be widely distributed in 2020, adding that his “central expectation” is for roll-out in the first half of 2021. … Read More >‘We’re not there yet’: British health minister dashes hopes AstraZeneca vaccine could be ready before Christmas

USA

Johnson & Johnson, AstraZeneca to Resume Coronavirus Vaccine Clinical Trials in US

Posted on October 24, 2020October 24, 2020By Editor

American pharmaceutical company Johnson & Johnson announced halting its COVID-19 vaccine clinical trials on 12 October after one of its program participants exhibited an “unexplained illness”. The British company paused worldwide trials on 6 September after it was revealed that neurological illnesses were being reported among participants. … Read More >Johnson & Johnson, AstraZeneca to Resume Coronavirus Vaccine Clinical Trials in US

Second AstraZeneca volunteer reportedly suffers rare neurological condition, but UK company says it’s not related to vaccine

Posted on September 22, 2020September 22, 2020By Editor

Two people have fallen ill during the trials of AstraZeneca’s coronavirus vaccine in the UK, the company’s internal papers revealed, and a source said they had both suffered from the same serious neurological disorder. … Read More >Second AstraZeneca volunteer reportedly suffers rare neurological condition, but UK company says it’s not related to vaccine